KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Goodwill (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Goodwill readings, the most recent being $15.8 billion for Q1 2026.

  • On a quarterly basis, Goodwill rose 2.23% to $15.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $15.8 billion, a 2.23% increase, with the full-year FY2025 number at $16.0 billion, changed 0.0% from a year prior.
  • Goodwill hit $15.8 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $16.0 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $20.0 billion in Q1 2022 to a low of $479.0 million in Q2 2022.
  • Median Goodwill over the past 5 years was $16.5 billion (2024), compared with a mean of $15.9 billion.
  • Biggest five-year swings in Goodwill: plummeted 97.65% in 2022 and later skyrocketed 3473.7% in 2023.
  • Teva Pharmaceutical Industries' Goodwill stood at $17.2 billion in 2022, then changed by 0.0% to $17.2 billion in 2023, then decreased by 6.85% to $16.0 billion in 2024, then changed by 0.0% to $16.0 billion in 2025, then decreased by 1.11% to $15.8 billion in 2026.
  • The last three reported values for Goodwill were $15.8 billion (Q1 2026), $16.0 billion (Q4 2025), and $15.9 billion (Q3 2025) per Business Quant data.